JP2017510590A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017510590A5 JP2017510590A5 JP2016559366A JP2016559366A JP2017510590A5 JP 2017510590 A5 JP2017510590 A5 JP 2017510590A5 JP 2016559366 A JP2016559366 A JP 2016559366A JP 2016559366 A JP2016559366 A JP 2016559366A JP 2017510590 A5 JP2017510590 A5 JP 2017510590A5
- Authority
- JP
- Japan
- Prior art keywords
- spiro
- methyl
- dihydro
- triaza
- diaza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14001145.3 | 2014-03-27 | ||
| EP14001145 | 2014-03-27 | ||
| PCT/EP2015/000528 WO2015144290A1 (en) | 2014-03-27 | 2015-03-10 | Pyridyl piperidines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017510590A JP2017510590A (ja) | 2017-04-13 |
| JP2017510590A5 true JP2017510590A5 (enExample) | 2018-04-19 |
| JP6434989B2 JP6434989B2 (ja) | 2018-12-05 |
Family
ID=50389770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016559366A Expired - Fee Related JP6434989B2 (ja) | 2014-03-27 | 2015-03-10 | ピリジルピペリジン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9926319B2 (enExample) |
| EP (1) | EP3122739B1 (enExample) |
| JP (1) | JP6434989B2 (enExample) |
| CN (1) | CN106458992B (enExample) |
| AU (1) | AU2015236855B2 (enExample) |
| CA (1) | CA2943659C (enExample) |
| ES (1) | ES2720324T3 (enExample) |
| IL (1) | IL247728B (enExample) |
| WO (1) | WO2015144290A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6447304B2 (ja) * | 2015-03-27 | 2019-01-09 | Jsr株式会社 | 液晶配向剤、液晶配向膜及びその製造方法、液晶表示素子、位相差フィルム及びその製造方法、重合体並びに化合物 |
| MX2017015456A (es) | 2015-06-01 | 2018-11-29 | Bantam Pharmaceutical Llc | Compuestos de pirazol y pirrol sustituidos y metodos para su uso por inhibición de iniciación de traducción y tratamiento de enfermedades y trastornos relacionados con ellos. |
| JP6977238B2 (ja) * | 2015-11-03 | 2021-12-08 | エルユー ライセンス エービーLu License Ab | 低増殖性障害の治療のための化合物 |
| MX2019006296A (es) | 2016-11-30 | 2019-11-12 | Bantam Pharmaceutical Llc | Métodos de uso de compuestos de pirazol y pirazol sustituido y para el tratamiento de enfermedades hiperproliferativas. |
| WO2018102453A1 (en) * | 2016-11-30 | 2018-06-07 | Bantam Pharmaceutical, Llc | Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases |
| CN114921468A (zh) | 2017-01-30 | 2022-08-19 | 国立大学法人京都大学 | 新型化合物以及调节性t细胞的制造方法 |
| EP3691642B1 (en) | 2017-10-02 | 2024-03-06 | Boehringer Ingelheim International GmbH | [1,6]naphthyridine compounds and derivatives as cdk8/cdk19 inhibitors |
| US20220396577A1 (en) * | 2019-12-17 | 2022-12-15 | Merck Sharp & Dohme Llc | Novel substituted 1,3-8-triazaspiro[4,5] decane-2,4-dione compounds as indoleamine 2,3-dioxygenase (ido) and/or tryptophan 2,3-dioxygenase (tdo) inhibitors |
| EP4410965A4 (en) | 2021-09-27 | 2025-09-24 | Univ Kyoto | T LYMPHOCYTE PRODUCTION PROCESS |
| EP4438048A4 (en) | 2021-11-24 | 2025-10-22 | Regcell Co Ltd | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED TO T LYMPHOCYTES |
| TW202330911A (zh) | 2021-11-24 | 2023-08-01 | 日商雷格細胞股份有限公司 | 人類誘導性控制性ｔ細胞及其製作方法 |
| WO2023182328A1 (ja) | 2022-03-23 | 2023-09-28 | 国立大学法人京都大学 | 制御性ｔ細胞の製造方法 |
| KR20250077533A (ko) | 2022-09-26 | 2025-05-30 | 고쿠리츠 다이가쿠 호진 교토 다이가쿠 | T 세포 제조 방법 |
| EP4596684A1 (en) | 2022-09-26 | 2025-08-06 | Regcell Co., Ltd. | Induced regulatory t cells containing chimeric antigen receptor (car) |
| CN120676951A (zh) | 2023-02-08 | 2025-09-19 | 雷格细胞股份有限公司 | 用于治疗或预防天疱疮的药物组合物 |
| WO2024204553A1 (ja) | 2023-03-29 | 2024-10-03 | レグセル株式会社 | ヒト誘導性制御性ｔ細胞およびその作製方法、およびｔ細胞関連疾患を治療または予防するための医薬組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0818241D0 (en) * | 2008-10-06 | 2008-11-12 | Cancer Res Technology | Compounds and their use |
| EP2638025B1 (en) * | 2010-11-12 | 2020-02-05 | Deutsches Krebsforschungszentrum (DKFZ) | Chromene derivatives and their analoga as wnt pathway antagonists |
| PH12017500997A1 (en) * | 2012-04-04 | 2018-02-19 | Samumed Llc | Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| ME03573B (me) * | 2012-05-04 | 2020-07-20 | Samumed Llc | 1H-PIRAZOLO[3,4-B]PIRIDINI l NJIHOVA TERAPEUTSKA UPOTREBA |
| CN104755477B (zh) * | 2012-10-08 | 2017-09-26 | 默克专利股份公司 | 2‑氨基吡啶化合物 |
-
2015
- 2015-03-10 CN CN201580027519.1A patent/CN106458992B/zh not_active Expired - Fee Related
- 2015-03-10 EP EP15709097.8A patent/EP3122739B1/en not_active Not-in-force
- 2015-03-10 AU AU2015236855A patent/AU2015236855B2/en not_active Ceased
- 2015-03-10 ES ES15709097T patent/ES2720324T3/es active Active
- 2015-03-10 JP JP2016559366A patent/JP6434989B2/ja not_active Expired - Fee Related
- 2015-03-10 WO PCT/EP2015/000528 patent/WO2015144290A1/en not_active Ceased
- 2015-03-10 CA CA2943659A patent/CA2943659C/en active Active
- 2015-03-10 US US15/129,338 patent/US9926319B2/en not_active Expired - Fee Related
-
2016
- 2016-09-08 IL IL247728A patent/IL247728B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI879728B (zh) | Shp2磷酸酶抑制劑及其使用方法 | |
| JP2016500694A5 (enExample) | ||
| EP3630770B1 (en) | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors | |
| JP6631616B2 (ja) | ＣＤＫ阻害剤としての２−アミノ−ピリド［２，３−ｄ］ピリミジン−７（８Ｈ）−オン誘導体及びその使用 | |
| DE60208792T2 (de) | Tyrosin-kinase inhibitoren | |
| EP2953940B1 (en) | Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic m4 receptor agonists | |
| EP4010335A1 (en) | Shp2 inhibitors | |
| BR112019018991A2 (pt) | compostos e composições para tratar distúrbios hematológicos | |
| JP2013539777A5 (enExample) | ||
| AU1091301A (en) | Tyrosine kinase inhibitors | |
| KR20230107419A (ko) | 암 치료 방법 | |
| JP2019508384A (ja) | ５−置換２−（モルホリン−４−イル）−１，７−ナフチリジン | |
| JP2010513495A (ja) | 新規なｊｎｋ阻害剤 | |
| WO2003009852A1 (en) | Tyrosine kinase inhibitors | |
| JP2010535201A (ja) | 抗癌治療としての抗有糸分裂薬およびオーロラキナーゼ阻害薬 | |
| KR20150120383A (ko) | 신규 피라졸 유도체 | |
| KR20160056896A (ko) | Ｐｉｍ 키나아제 억제제로서 유용한 푸로- 및 티에노-피리딘 카복사미드 화합물 | |
| AU2013243020A1 (en) | Cyclic amides as MetAP-2 inhibitors | |
| TW201822764A (zh) | Syk抑制劑 | |
| WO2012082689A1 (en) | SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS | |
| AU2011344001A1 (en) | Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors | |
| WO2014151936A9 (en) | Octahydropyrrolopyrroles, their preparation and use | |
| WO2013117645A1 (en) | Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases | |
| JP2014514317A (ja) | 二環式複素環化合物および治療法におけるその使用 | |
| BR112020022088A2 (pt) | moduladores alostéricos de espiropiperidina de receptores nicotínicos de acetilcolina |